SCHEMBL6570090

SCHEMBL6570090

CNc1ccccc1C(=O)N/N=C\c1cc(O)ccc1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.60
MGAM O43451 1/20 0.58
GAA P10253 1/20 0.58
SI P14410 1/20 0.58
MGAM2 Q2M2H8 1/20 0.58
KDM4E B2RXH2 3/20 0.56
KMT2A Q03164 3/20 0.56
MEN1 O00255 2/20 0.56
TP53 P04637 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
HPGD P15428 1/20 0.56
MAPK1 P28482 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
TUBB8B A6NNZ2 1/20 0.55
EGFR P00533 1/20 0.55
TUBB4A P04350 1/20 0.55
TUBB P07437 1/20 0.55
TUBA3C P0DPH7 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6570093 1.00 NTRK1 (0.60) NTRK1MGAMGAASIMGAM2
SCHEMBL6568466 0.88 KMT2A (0.71) NTRK1KDM4EKMT2AMEN1TP53
SCHEMBL6568468 0.88 KMT2A (0.71) NTRK1KDM4EKMT2AMEN1TP53
SCHEMBL684522 0.87 KMT2A (0.74) NTRK1MGAMGAASIMGAM2
SCHEMBL6570171 0.82 KDM4E (0.77) NTRK1MGAMGAASIMGAM2
SCHEMBL6570164 0.82 KDM4E (0.77) NTRK1MGAMGAASIMGAM2
SCHEMBL6568234 0.80 KMT2A (0.77) NTRK1MGAMGAASIMGAM2
SCHEMBL6568237 0.80 KMT2A (0.77) NTRK1MGAMGAASIMGAM2
SCHEMBL14983736 0.80 AR (0.80) NTRK1MGAMGAASIMGAM2
SCHEMBL6568355 0.79 KDM1A (0.69) NTRK1MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110963-A1 Novel hydrazones ARPIDA AG (CH) 2004-06-10 US claimed
US-20040110963-A1 Novel hydrazones ARPIDA AG (CH) 2004-06-10 US disclosed
EP-1404644-A2 NOVEL HYDRAZONES Arpida AG, (CH) 2004-04-07 EP disclosed
WO-2002070464-A2 HYDRAZONES AND THEIR THERAPEUTIC USE ARPIDA AG (CH) 2002-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110963-A1 Novel hydrazones H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HK1, MPO NTRK1 4662/4885MGAM 1345/4885GAA 588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.